{
    "Trade/Device Name(s)": [
        "Liquichek Qualitative Urine Toxicology Control"
    ],
    "Submitter Information": "Bio-Rad Laboratories",
    "510(k) Number": "K052053",
    "Predicate Device Reference 510(k) Number(s)": [
        "K033366",
        "K001973"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "DIF"
    ],
    "Summary Letter Date": "August 9, 2005",
    "Summary Letter Received Date": "July 29, 2005",
    "Submission Date": "July 25, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.3280"
    ],
    "Regulation Name(s)": [
        "Clinical Toxicology control material"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Oxycodone",
        "Amphetamines",
        "Barbiturates",
        "Benzodiazepines",
        "Benzoylecgonine",
        "Cannabinoids",
        "Cocaine",
        "d-Amphetamine",
        "d-Methamphetamine",
        "Ethanol",
        "LSD",
        "MDMA (Ecstasy)",
        "Methadone",
        "Methaqualone",
        "Morphine (Free)",
        "Nordiazepam",
        "Nortriptyline",
        "Opiates",
        "Oxazepam",
        "Phencyclidine",
        "Propoxyphene",
        "Secobarbital",
        "Tricyclic Antidepressants (TCA)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Bio-Rad Liquichek Qualitative Urine Toxicology Control as a quality control for qualitative urine toxicology testing including Oxycodone.",
    "Indications for Use Summary": "Intended for use as an assayed quality control urine to monitor the performance of laboratory procedures for qualitative urine toxicology.",
    "fda_folder": "Toxicology"
}